Avoid biotech until elections? Analyst's view

12:44 PM ET Mon, 8 Feb 2016

The number one biotech analyst Mark Schoenebaum, Evercore ISI pharma analyst, weighs in on the selloff in the space, and which stocks have the potential to go higher this year.